Q4 2024 · 13F-HR
Stonepine Capital Management, LLCholdings as filed
Filed 2025-02-14 · accession 0000935836-25-000151
$123.9M
Reported value
52
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 000899104 | ADMA | ADMA BIOLOGICS INC | $21.3M | 17.2% | 1,241,032 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $14.0M | 11.3% | 1,264,651 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $7.1M | 5.74% | 2,353,099 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV-SPON ADR | $5.5M | 4.44% | 200,000 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $5.0M | 4.02% | 597,700 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $4.5M | 3.63% | 870,000 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $4.0M | 3.26% | 220,000 | Common | SOLE |
| 68404V209 | OPTNUSD | OPTINOSE INC | $3.9M | 3.17% | 588,657 | Common | SOLE |
| 035255108 | ANIK | ANIKA THERAPEUTICS INC | $3.9M | 3.17% | 238,222 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $3.8M | 3.06% | 305,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HOLDINGS | $3.7M | 2.98% | 80,002 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $3.7M | 2.97% | 1,132,388 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $3.5M | 2.79% | 324,324 | Common | SOLE |
| 98419J206 | XOMA | XOMA CORP | $3.3M | 2.67% | 125,700 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $3.0M | 2.40% | 235,000 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $2.9M | 2.32% | 648,785 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $2.4M | 1.95% | 683,530 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $2.0M | 1.59% | 137,200 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $1.9M | 1.55% | 1,050,000 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $1.9M | 1.54% | 331,900 | Common | SOLE |
| 62857J201 | MYO | MYOMO INC | $1.8M | 1.43% | 274,426 | Common | SOLE |
| 38942Q202 | CALC | CALCIMEDICA INC | $1.7M | 1.34% | 468,793 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $1.6M | 1.33% | 663,405 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MEDICAL CORP | $1.5M | 1.21% | 200,000 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC US LISTED | $1.2M | 0.99% | 10,000 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $1.2M | 0.97% | 164,106 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.2M | 0.95% | 500,000 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $1.1M | 0.91% | 20,400 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $1.1M | 0.86% | 700,000 | Common | SOLE |
| 30068X103 | XGN | EXAGEN INC | $1.0M | 0.83% | 251,049 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $882,000 | 0.71% | 300,000 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $844,800 | 0.68% | 110,000 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $809,066 | 0.65% | 535,805 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $739,200 | 0.60% | 110,000 | Common | SOLE |
| 054754858 | AYTU | AYTU BIOPHARMA INC | $692,833 | 0.56% | 407,549 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $673,400 | 0.54% | 700,000 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $663,201 | 0.54% | 200,970 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $618,055 | 0.50% | 182,317 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $569,600 | 0.46% | 160,000 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $490,937 | 0.40% | 149,221 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $417,212 | 0.34% | 132,870 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $345,000 | 0.28% | 250,000 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $315,151 | 0.25% | 103,668 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $273,958 | 0.22% | 132,347 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $271,490 | 0.22% | 196,732 | Common | SOLE |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $119,750 | 0.10% | 25,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $112,520 | 0.09% | 200,000 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $109,800 | 0.09% | 15,000 | Common | SOLE |
| 016CVR029 | — | ALIMERA SCIENCES INC CVR | $107,124 | 0.09% | 2,408,469 | Common | SOLE |
| 016744500 | ALLR | ALLARITY THERAPEUTICS INC | $78,728 | 0.06% | 67,289 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $70,723 | 0.06% | 23,264 | Common | SOLE |
| 023111206 | — | AMARIN CORPORATION PLC -ADR | $55,415 | 0.04% | 114,257 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.